Subscribe
Subscribe
Picture of QbD Group

QbD Group

QbD Group is your European gateway and strategic life science partner guiding innovations from idea to patient. From startups to global leaders in Pharma, Biotech, MedTech, and IVD, we deliver tailored support in regulatory, clinical, and operational excellence. With 650+ experts worldwide, we combine deep domain knowledge with a hands-on, solution-driven mindset to accelerate development, ensure compliance, and maximize product success across the full lifecycle.
Picture of QbD Group

QbD Group

QbD Group is your European gateway and strategic life science partner guiding innovations from idea to patient. From startups to global leaders in Pharma, Biotech, MedTech, and IVD, we deliver tailored support in regulatory, clinical, and operational excellence. With 650+ experts worldwide, we combine deep domain knowledge with a hands-on, solution-driven mindset to accelerate development, ensure compliance, and maximize product success across the full lifecycle.

Safer drugs through smarter governance: How to strengthen global pharmacovigilance

Pharmacovigilance rarely makes headlines—until something goes wrong. A missed signal or a lack of coordination can have serious consequences when dealing with drugs. In today’s globalized biopharma landscape, pharmacovigilance isn’t just a box to tick—it’s a critical safeguard for both companies and the patients they serve. So how can companies improve their project governance to keep everyone safe?

From idea to patient: how QbD Group empowers life sciences across Europe

Bringing a life science innovation to market is a complex journey, one that requires more than just scientific expertise. It involves working through a demanding regulatory landscape, managing clinical trials, ensuring operational compliance, and maintaining a continuous focus on quality. BioVox’s partner the QbD Group understands these challenges firsthand, because they’ve been guiding life science companies towards success for over a decade.